Compositions and methods for inhibiting arginase activity
US12054501B2 · kind B2 · utility
0Cited by
28References
6Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jan 20, 2021 |
| Grant date | Aug 6, 2024 |
| Priority date | — |
| Expiry date | Oct 1, 2041 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K2300/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The disclosure relates to a novel class of compounds that exhibit activity inhibitory activity toward arginase, and pharmaceutical compositions comprising the compounds of the disclosure. Also provided herein are methods of treating cancer with the arginase inhibitors of the disclosure.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.